Data protection Impressum

Life sciences

To meet the growing demand for hybrid expertise at the crossroads of life sciences and digital technologies, HES-SO Valais-Wallis has introduced a pioneering specialization in Digital Life Sciences, the first of its kind in Western Switzerland.

HES-SO introduces the first Digital Life Sciences program in Western Switzerland

10 December 2024

Rhovica Neuroimaging AG, an innovative bernse medtech start-up, has announced a strategic partnership with M2care, a European venture studio specializing in health technologies. This collaboration aims to accelerate the development and commercialization of Rhovica’s cutting-edge solutions in neurocritical care.

Rhovica Neuroimaging partners with M2care to advance neurosurgery

9 December 2024

Biopôle, the renowned life sciences campus in Epalinges-Lausanne, celebrates 20 years of groundbreaking achievements with the inauguration of the Leucine Building.

Biopôle celebrates 20 years of innovation with the inauguration of the Leucine building

9 December 2024

Siegfried, a prominent Swiss Contract Development and Manufacturing Organization (CDMO), has unveiled its new global Research and Development (R&D) center at its site in Evionnaz, in the canton of Valais.

Siegfried has inaugurated its global R&D center in Evionnaz

4 December 2024

Biolux Technology, a Geneva-based pioneer in light-accelerated orthodontics, has raised CHF 4 million in seed funding to revolutionize orthodontic care with cutting-edge digital solutions.

Geneva’s Biolux Technology secures CHF 4 million to advance orthodontic innovation

20 November 2024

Bracco, a global leader in diagnostic imaging, has unveiled its state-of-the-art facility in Geneva, marking a significant milestone in advancing contrast-enhanced ultrasound (CEUS) technology.

Bracco boosts ultrasound imaging capabilities with new Geneva facility

19 November 2024

Lonza strengthens its bioconjugation capabilities in Visp with two major expansions, adding three new suites and creating 300 jobs to meet growing demand.

Lonza expands bioconjugation capacity in Visp and creates 300 jobs

12 November 2024

Swissmedic, Switzerland's national regulatory authority for therapeutic products, has strengthened its role in the global healthcare landscape through strategic collaborations and innovations in regulatory science. From cross-border initiatives to advances in digital transformation, Swissmedic is positioning itself as a leader in efficient, high-quality regulatory processes, providing Swiss patients with safe and timely access to cutting-edge therapies.

Swissmedic reinforces Switzerland’s role in global regulatory collaboration and advanced therapeutics

11 November 2024

Bernese start-up AlveoliX has published a study confirming the efficacy of its Lung-on-Chip model the study of respiratory diseases. The study, conducted with leading academic and industrial partners, demonstrates the model's potential for personalized and ethical testing.

AlveoliX achieves breakthrough with Lung-on-Chip model in respiratory research

4 November 2024

Ikerian has raised USD 8 million in Series B funding to advance Discovery CONNECT, a platform that optimizes data management in ophthalmology clinics. Lead investor Sanoptis has entered a strategic partnership to distribute the platform across its European network.

Ikerian secures USD 8 million and a strategic partnership with Sanoptis

29 October 2024

1 … 4 5 6 7 8 9 10 11 12 … 44